2009-05-29 |
rTMS-stroke-phase I |
CIREN |
Registered |
02/11/2021 |
Moringa in Diabetes |
CIPPPB |
Registered outdated |
2012-09-17 |
iorEPOCIM-Stroke-Phase I |
CIMAB |
Registered outdated |
2013-02-01 |
Nimotuzumab in tumors of head and neck .Phase IV |
CIMAB |
Registered |
2013-02-01 |
Nimotuzumab for the treatment of high grade of malignancy tumors |
CIMAB |
Registered |
2013-02-26 |
ior EPOCIM ® in the management of anemia of the preterm infant.Phase IV. |
CIMAB |
Registered |
2011-11-11 |
Effectiveness and safety of ior®EPOCIM in Chronic Kidney Disease patients in pre-dialysis. |
CIMAB |
Registered |
2009-07-03 |
Therapeutic Equivalence between ior EPOCIM and EPO without albumin, for patients with Chronic Renal failure on Peritoneal dialysis methods.(Hemodialysis or peritoneal dialysis). |
CIMAB |
Registered |
2009-07-03 |
Safety evaluation of Recombinant Human Erythropoietin ior EPOCIM in the treatment of patient with cerebral infarction acute. Study Stage I. |
CIMAB |
Registered outdated |
2009-07-03 |
Impact of Human Recombinant Erithoropoietin (ior EPOCIM) in cancer patients with post Chemo and Radiotherapy induced anemia. |
CIMAB |
Registered |
2009-07-03 |
Impact of Recombinant Human Erythropoietin (ior EPO-CIM) in oncology pediatric patients with post chemo and /or radiotherapy. |
CIMAB |
Registered |
2009-07-10 |
Effectiveness and Safety of ior EPOCIM in patients with Chronic Renal Failure on dialysis methods. |
CIMAB |
Registered |
2009-07-24 |
Safety assessment of Granulocyte Colony Stimulating Factor:ior LeukoCIM in oncohematologic patients.Phase IV study. |
CIMAB |
Registered |
2009-07-24 |
Impact of the Granulocytes Colony-Stimulating Factor (ior-LeukoCIM) in primary and secondary prophylaxis and post chemotherapy and/or radiotherapy neutropenia in oncohematological pediatric patients. |
CIMAB |
Registered |
2009-08-20 |
Effectiveness and Safety of use ior LeukoCIM as prophylaxis and treatment of Neutropenia in patients with HIV / AIDS. |
CIMAB |
Registered |
2009-09-18 |
Effectiveness and Safety of Nimotuzumab for the treatment of patients with glioma tumors |
CIMAB |
Registered |
2009-10-22 |
Effectiveness and safety of ior EPOCIM in anemia in premature infant. |
CIMAB |
Registered |
2009-10-22 |
Nimotuzumab- Head and neck cancer |
CIMAB |
Registered |
2009-10-23 |
EPOCIM in benign prostatic hyperplasia. |
CIMAB |
Registered |
2010-06-11 |
Effect and Safety of ior® EPOCIM in patients with Non-Hodking Lymphoma treated with anthracyclines. |
CIMAB |
Registered |